A detailed history of Proffitt & Goodson Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Proffitt & Goodson Inc holds 200 shares of FLGT stock, worth $3,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$3,292
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$16.71 - $22.68 $3,342 - $4,536
200 New
200 $3,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $498M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Proffitt & Goodson Inc Portfolio

Follow Proffitt & Goodson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Proffitt & Goodson Inc with notifications on news.